Used Car..
Uco (used cooking oil).
Used Mobile Phones.
Bags like fashion bags, shoulder bag and shopping bag.
Used laptops and used iphones.
I am representing SD Biosensor from South Korea that manufactures US FDA EUA approved Standard M nCo V Real-Time Detection Kit (COVID Testing kit). We have received US FDA EUA approval to export Covid 19 detection kit in April and can directly export from Korea. SD Biosensor is one of the few companies that has received US FDA approvals and have already sold 1.5 million testing units to US government (Based on US government reaching out to South Korea Government for help with procuring Covid Testing kits). I'm currently in Seoul, South Korea but I'm a US citizen helping SD Biosensor as an agent to help buyers procure these testing kits. This company has capability to manufacture over 600,000 testing units a day and have enough supplies readily available for an immediate export. Please email me at Jinsoo.park@yahoo.com to receive US FDA EUA Approval and product information. rapid test kits which are not FDA approved are in the low to mid $20 range and the price for FDA EUA approved standard test kits are around high $20s to low $30s and depending on the contract length and quantity we have some room for negotiation. Also these kits have to be refrigerated shipped so there will be some additional cost for this.
Jute bags and sacks.
Jute bags/sack/tape/raw jute btd bte.
Women Bag .
Used phone.
Used phone.
Used computer parts such as HDD, memory, CPU & mainboard..
Used Heavy Machinery.
Food package bag.
Used mobile phone.
Used Cooking Oil..
Used korean mobile.
Used mobile phones.
Used mobile phones.
DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit Real-Time OneStep RT-PCR based assay system for detection of SARS-CoV-2 [Product Approval] U.S FDA EUA, Health Canada IO, CE-IVD marked The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. The agent detected may not be the definite cause of disease. Positive results do not rule out bacterial infection or co-infection with other viruses. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.